Recent CDMO Stock Price | CDMO Stock Predictions | |
$6.70 | +82.84% |
$12.25 |
Recent CDMO Analyst Ratings Breakdown, Making CDMO Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 3 | 3 | 3 | 3 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 1 | 1 | 1 | 1 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.6 | 1.6 | 1.6 | 1.6 |
For the CDMO stock predictions from the analysts covering Avid Bioservices Inc, we have collected all of the individual CDMO stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 4 different analysts covering CDMO (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since CDMO stock predictions may vary widely, another useful metric to consider is the median CDMO stock prediction, which represents the price at which half of the analysts
made CDMO stock predictions that were higher and half made CDMO stock predictions that were lower. This makes for a different take on the CDMO stock predictions out there, as compared to average or mean.
And that median across all the individual CDMO stock predictions was: $13.0 as of 2024-03-29.
The very highest of the CDMO stock predictions for one year price target was $16.0, while the very lowest of the CDMO stock predictions in the analyst group was
$7.0 (with a standard deviation of $3.862). Get the latest Zacks research report on CDMO — FREE
Find out: CDMO next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
RVNC Stock Predictions
ALL Stock Predictions
RNDB Stock Predictions
EYEG Stock Predictions
DG Stock Predictions
BMY Stock Predictions
PWR Stock Predictions
WRLD Stock Predictions
STAY Stock Predictions
|
CDMO Next Dividend Date » (Projection based upon history) CDMO Dividend Growth Rate » Quotes delayed 20 minutes |
Buy (3.40 out of 4) 56th percentile
(ranked higher than approx. 56% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |